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Abstract 
Background: The current therapy for inflammatory and autoimmune disorders involves the use of nonspecific anti-
inflammatory drugs and other immunosuppressant, which are often accompanied with potential side effects. As an 
alternative therapy, anti-inflammatory peptides are recently being exploited as anti-inflammatory agents for treat-
ment of various inflammatory diseases such as Alzheimer’s disease and rheumatoid arthritis. Thus, understanding the 
correlation between amino acid sequence and its potential anti-inflammatory property is of great importance for the 
discovery of novel and efficient anti-inflammatory peptide-based therapeutics.
Methods: In this study, we have developed a prediction tool for the classification of peptides as anti-inflammatory 
epitopes or non anti-inflammatory epitopes. The training was performed using experimentally validated epitopes 
obtained from Immune epitope database and analysis resource database. Different sequence-based features and 
their hybrids with motif information were employed for development of support vector machine-based machine 
learning models. Similarly, machine learning models were also constructed using random forest.
Results: The composition and terminal residue conservation analysis of peptides revealed the dominance of leucine, 
serine, tyrosine and arginine residues in anti-inflammatory epitopes as compared to non anti-inflammatory epitopes. 
Similarly, the anti-inflammatory epitopes specific motifs were found to be rich in hydrophobic and polar residues. The 
hybrid of tripeptide composition-based support vector machine model and motif yielded the best performance on 
10-fold cross validation with an accuracy of 78.1% and MCC of 0.58. The same displayed an accuracy of 72% and MCC 
of 0.45 on validation dataset, rejecting any possibility of over-fitting. The tripeptide composition-based random forest 
model displayed an accuracy of 0.8 and MCC of 0.59 on 10-fold cross validation, however, the accuracy (0.68) and 
MCC (0.31) was lower as compared to support vector machine model on validation dataset. Thus, the support vector 
machine model is implemented as the default model and an additional option of using the random forest model is 
provided.
Conclusion: The prediction models along with tools for epitope mapping and similarity search have been provided 
as a web server which is freely accessible at http://metagenomics.iiserb.ac.in/antiinflam/.
© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
For maintenance of immune homeostasis and restricting 
the occurrence of aggravated inflammation and autoim-
munity, the induction of immune tolerance is crucial [1]. 
The effect of multiple mechanisms working in concert is 
necessary for the upkeep of the state of tolerance. Several 
endogenous peptides identified during inflammatory 
responses have emerged as anti-inflammatory agents 
that can be employed in new therapies for inflammatory 
and autoimmune conditions [2]. The immunotherapeutic 
ability of these anti-inflammatory peptides in the inhibi-
tion of antigen-specific T(H)1-driven responses, and in 
the generation of regulatory T cells has numerous clinical 
applications [3].
Several synthetic and natural peptides are known to 
inhibit the signal transduction pathways for expres-
sion of inflammatory cytokines. For example, intrana-
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with neuropathological symptoms of Alzheimer’s dis-
ease showed a decreased A-beta plaque burden along 
with anti-inflammatory cytokines IL-4, IL-10 and tumor 
growth factor-beta [4]. Another neuropeptide: vasoac-
tive intestinal peptide (VIP) is also known to reduce the 
inflammatory and autoimmune components of rheuma-
toid arthritis in the experimental model [5]. Similarly, 
there are pieces of evidence showing production of pro-
inflammatory cytokines and microglial activation during 
age-related cognitive deficits in the hippocampal region. 
A mimetic peptide FG Loop(FGL) derived from the neu-
ral cell adhesion molecule (NCAM) is shown to work as 
a novel anti-inflammatory agent in such age-related dis-
orders [6]. Furthermore, nonapeptides, Anti inflammin 
1 and 2, can potentially reduce leukocyte trafficking in 
host defense and inflammation by inhibiting PMN adhe-
sion to HCAEC by attenuating up-regulation of CD11/
CD18 expression on leukocytes [7]. Moreover, certain 
synthetic peptides are known to be involved in inhibi-
tion of early signal transduction pathways of inflam-
matory cytokines. One notable example is the role of 
intravesical RDP58 in interstitial cystitis (IC) inflamma-
tion-induced neurotrophic changes in the bladder. Mice 
models treated with RDP58 shows near complete aboli-
tion of LPS induced production of TNF-α in the bladder 
[8].
Taken together, the availability of experimental data 
allows for the computational correlation between amino 
acid sequences and their anti-inflammatory properties. 
To the best of the authors’ knowledge, there has been 
no study that investigates the sequence based signature 
for the anti-inflammatory behavior of target peptide 
sequences. Understanding the association between spe-
cific amino acid sequences and the anti-inflammatory 
properties conferred by them is likely to facilitate their 
application for therapeutic purposes. One such exam-
ple is of altered peptide ligands (APLs) and their role in 
therapeutic modulation of T cell function [9]. The aim 
of this study was to examine the amino acid sequences 
of experimentally validated anti-inflammatory epitopes 
(AIEs) and non anti-inflammatory epitopes (NAIEs) and 
develop a machine learning based classification method 
that incorporates the sequence based features to predict 




An unambiguous and well-curated dataset is required for 
machine-learning based model building. Thus, the posi-
tive and negative assaying epitopes were retrieved from 
the immune epitope database [10]. A peptide was con-
sidered as anti-inflammatory if it was shown to induce 
any one of the anti-inflammatory cytokines [IL-10, IL-13, 
IL-22, IL-1RA, TGFβ, IFN-α/β] [11]. 863 epitopes were 
reported to show a positive assay, whereas, 1261 peptides 
tested negative for anti-inflammatory cytokines and were 
classified as NAIEs. The length of these epitopes ranged 
between 4 and 30 amino acids residues. Out of the total 
input dataset, 80% of both AIEs and NAIEs were assigned 
as training dataset and the remaining 20% constituted the 
validation dataset. Resultantly, a total of 690 AIEs (posi-
tive data) and 1009 NAIEs (negative data) constituted 
the training dataset, and the validation dataset contained 
173 AIEs (positive data) and 253 NAIEs (negative data) 
(Fig. 1). Two datasets were constructed on which the var-
ious analysis were carried out in this manuscript, namely, 
(1) realistic dataset with all available positive and nega-
tive epitopes, and (2) balanced dataset including all posi-
tive epitopes (690 positives) and randomly chosen equal 
number of negative epitopes (690 negatives).
Input features for machine learning
Composition‑based features
Amino acid composition Amino acid composition 
(AAC) is a widely used feature in composition-based pep-
tide classification methods [12, 13]. It is the percentage of 
each amino acid in a given length of the peptide sequence. 
Each peptide/protein can be represented as a vector of 
20 features (composition of 20 naturally occurring amino 
acids).
where, AAC is the amino acid composition of an amino 
acid (i) which is one of the 20 amino acids.
Dipeptide composition Several immune epitope predic-
tion algorithms and numerous composition-based algo-
rithms use dipeptide composition (DPC) for classification 
[14, 15]. DPC is the percentage composition of each of the 
400 possible dipeptides formed by 20 amino acids. Unlike 
AAC, DPC carries the additional information of local 
arrangement in a peptide/protein since it is the pair of 
adjacently placed amino acids. DPC was calculated using 
the following equation.
where Dp(n) is a dipeptide n out of 400 dipeptides.
Tripeptide composition Tripeptide composition (TPC) 
is the percentage composition of each of the 8000 possible 
dipeptides formed by 20 amino acids and was calculated 
using the following formula. It can also be used for com-
position-based classification [16].
AAC(i) = Total number of amino acid (i)
Total number of all possible amino acids
× 100
DPC(i) = Total number of dipeptides (i)
Total number of all possible dipeptides
× 100
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where TPC(n) is a tripeptide n out of 8000 tripeptides.
Motif‑based features
Identification of functional motifs in amino acid sequences 
is one of the widely used techniques in the functional 
annotation of peptides/proteins. Several previous immu-
noinformatics studies have examined the immunologically 
TPC(i) = Total number of tripeptides (i)
Total number of all possible tripeptides
× 100 relevant motifs in peptides for various purposes [17–19]. To identify the motifs specific to AIEs by comparing it with 
NAIEs, MERCI software was used [20]. The identification 
of motifs in positive data by comparing with negative data 
yields motifs exclusive for the positive data. Motifs specific 
for NAIEs were also identified by MERCI software in a 
similar manner. The maximum length of the motif was set 
to 9 amino acids because the core size of both MHC I and 
II equals nine amino acids [21, 22]. The gap length was set 
to the default length of 1.
Fig. 1 Flowchart showing steps involved in the development of prediction model and web server
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Hybrid feature
Hybrid models of AAC, DPC, and TPC with MERCI-
based motifs were also constructed in this study [23, 24]. 
The presence of anti-inflammatory and non anti-inflam-
matory specific motifs in every peptide in the training 
dataset was examined. If the epitope contained the anti-
inflammatory motifs, a weightage of +1 was added to 
its AAC, DPC or TPC based SVM score. Similarly, if the 
epitope is positive for non anti-inflammatory motifs, the 
weight was added as −1 for the same.
Machine‑learning‑based prediction models
Caret package in R was used to evaluate the perfor-
mance of various machine learning methods such as 
support vector machine (SVM), Random Forest (RF), 
k-nearest neighbors (kNN), linear discriminant analy-
sis (LDA) and classification and regression tree (CART). 
Based on the results, SVM and RF were used as the 
machine learning algorithms for building predictive 
models through SVMlight package available at http://
svmlight.joachims.org/ and randomForest package 
available at https://cran.r-project.org/web/packages/
randomForest/index.html. Machine learning algorithms 
have also been used in previous studies for developing 
tools for immune epitope prediction with good perfor-
mances [15, 25–28].
Performance evaluation of models
The comparison of different machine learning meth-
ods to select the best method is essential in predictive 
modelling. A 10-fold cross-validation technique was 
employed for different learning methods and evaluated 
on a separate unseen validation dataset. To carry out 
the 10-fold cross-validation, the data was divided into 
ten parts of which nine parts were used for training and 
the tenth segment was used for testing. The procedure is 
repeated ten times to test the learning methods on each 
part. The result of all ten predictions was taken together 
for evaluating the performance of various models built 
by different methods. For measuring the performance 
of each model, threshold dependent and threshold inde-
pendent parameters were used. For all models, area 
under curve (AUC), a threshold independent parameter 
was calculated using PERF [29]. Threshold-dependent 
parameters such as sensitivity (Sen), specificity (Spec), 
accuracy (Acc) and Matthews’s correlation coefficient 
(MCC) were also calculated for all models. The follow-
ing equations were used for calculating the threshold 
dependent parameters.
In addition, a fivefold cross validation study was also 
carried out and performance was compared with the 
10-fold cross validation study.
(TN  =  true negative, FP  =  false positive, TP  =  true 




To carry out the compositional analysis of AIEs and 
NAIEs, the frequencies of all amino acids (AAC), dipep-
tides (DPC), and tripeptides (TPC) were calculated in 
the peptides included in the two sets. The AAC analysis 
of AIEs revealed higher abundance of Leu, Ser, Tyr, Gln 
and Arg (Welch’s t test, p value ≤0.05) (Fig. 2). Similarly 
for NAIEs, Ala, Gly, Asp, Thr and Pro were observed 
in higher abundance (Welch’s t test, p value  ≤0.05).
The positional conservation of amino acids in AIEs and 
NAIEs was examined using a two sample logo (TSL) 
analysis (Fig.  3). Leu, Tyr, Ser, Arg and Glu were found 
as highly conserved at N-terminal of AIEs, whereas, 
Leu, Gln, Ser and Arg were found at C-terminal. In con-
trast, Ala, Gly, Val, Pro and Asp were highly conserved at 
N-terminal, whereas, Pro, Gly and Ala were found con-
served at C-terminal of NAIEs.
In DPC, from the 400 possible dipeptides, 54 signifi-
cant dipeptides (p value ≤0.01, Welch’s t-test) were found 
significantly different in AIEs as compared to NAIEs 
(Fig. 4). AIEs were found to be rich in Leu–Leu (LL), Ser–
Leu (SL), Leu–Glu (LE), Leu–Lys (LK), Arg–Leu (RL) 
and Tyr–Leu (YL) dipeptides, whereas, NAIEs were rich 
in Ala–Ala (AA), Ala–Thr (AT), Gly–Ala (GA), Gly–Pro 
(GP), Pro–Gly (PG), Pro–Pro (PP), Leu–Pro (LP) and 
Thr–Gly (TG) dipeptides.
Similarly, the TPC analysis also revealed several tripep-
tides which were highly abundant in AIEs as compared to 
NAIEs. A total of 122 tripeptides were found significantly 
abundant (p value ≤0.01, Welch’s t-test) in AIEs (Addi-
tional file 1: Table S1). In particular, Ser–Leu–Ser (SLS), 
Leu–Lys–Leu (LKL), Leu–Arg–Leu (LRL) etc. are highly 
abundant in AIEs and their constituent dipeptides and 
amino acids are also abundant in AAC and DPC analysis.
Accuracy = TP+ TN





MCC = (TP× TN)− (FP× FN)√
(TP+ FP)(TP+ FN)(TN+ FP)(TN+ FN) .
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HLA allele distribution
An analysis of the distribution of epitopes from IEDB 
database against different HLA alleles was also carried 
out (Fig.  5). Among the most contrasting results, most 
(50) of the peptides showed anti-inflammatory response 
against HLA-DRB1*04:01 in assays, whereas, only 14 
peptides showed non anti-inflammatory response against 
the same HLA allele. Similarly, the assays against H2-IAd 
allele included 25 unique NAIEs compared to 10 unique 
AIEs tested against the same HLA allele.
Motif analysis
Inflammatory responses arise due to the induction of T 
cells upon activation by antigen-presenting cells. In anti-
inflammatory response, MHC molecules on antigen pre-
senting cells present the bounded peptides and initiate 
the response. Peptide-MHC interaction occurs through 
specific amino acids in the form of motifs. Thus, the pres-
ence of these specific motifs can be utilized as a marker 
for better classification of peptides. MERCI software was 
used to predict specific motifs by comparing positive 
and negative datasets as explained in the “Methods” sec-
tion. 13 different specific motifs for AIEs were observed 
as shown in Table 1. The “hydrophobic hydrophobic tiny 
F charged” motif was found in 22 unique AIEs and had 
the highest observed motif coverage among all motifs.
Machine learning‑based classification
It is apparent from the earlier analysis that AIEs and 
NAIEs differ in several composition-based features. 
Therefore, these differences can be exploited for the classi-
fication of epitopes. Machine learning-based classification 
Fig. 2 Compositional analysis of AIEs and NAIEs
Fig. 3 Two sample logo showing positional conservation of five residues at both the terminals (N’- and C’-) in AIEs against NAIEs
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was implemented to exploit the sequence-specific features 
for the classification and prediction of AIEs and NAIEs.
Comparison of machine learning methods
Different machine learning algorithms such as SVM, RF, 
kNN, LDA and CART were implemented using caret 
package in R for comparing their performances on the 
same data. Performances of SVM and RF were found bet-
ter as compared to other machine learning techniques, 
and hence, these two machine learning methods were 
optimized further using amino acid, dipeptide and trip-
eptide composition as input features (Additional file  1: 
Text S1, Additional file  2: Figure S1, Additional file  3: 
Figure S2,  Additional file  4: Figure S3, Additional file  5: 
Figure S4, Additional file  6: Figure S5, Additional file  7: 
Figure S6, Additional file  8: Figure S7, Additional file  9: 
Figure S8, Additional file 10: Figure S9, Additional file 11: 
Figure S10 and Additional file 12: Figure S11).
Performance of SVM models
Amino acid composition‑based models
Compositional analysis revealed that AIEs and NAIEs 
show compositional differences. These characteristics 
were utilized to classify peptides into anti-inflammatory 
or non anti-inflammatory using machine learning mod-
els. SVM model with gamma parameter (g)  =  0.005, 
trade-off factor (c) = 1 and cost factor (j) = 1 produced 
the best classification in AAC-based models. It showed 
MCC of 0.37, accuracy of 68.16% and the area under 
curve (AUC) was found to be 0.74 (Fig. 6).
Fig. 4 Dipeptide composition distribution between AIEs and NAIEs (only significant dipeptides are shown with p value <0.01 in Welch’s t test)
Fig. 5 Distribution of HLA alleles among assays reporting AIEs and NAIEs
Page 7 of 11Gupta et al. J Transl Med  (2017) 15:7 
Dipeptide composition‑based models
Dipeptide composition was also used for building the 
predictive machine learning model using 400 sized vec-
tors representing all possible dipeptides. SVM model 
with gamma parameter (g)  =  0.005, trade-off factor 
(c) =  1 and cost factor (j) =  3 was the best performing 
model with an accuracy of 70.98, MCC of 0.44 and an 
area under curve (AUC) of 0.79 (Fig. 6).
Tripeptide composition‑based models
The local order in the form of DPC as feature yielded bet-
ter predictive ability of SVM model as compared to the 
results obtained using AAC. However, to further evaluate 
the effect of local order in the form of tripeptide, TPC as 
input feature was used to build the SVM model. The best 
model performed with an accuracy of 75.04%, MCC of 
0.51 and AUC of 0.81 on gamma parameter (g) = 0.001, 
trade-off factor (c) = 4 and cost factor (j) = 1 (Fig. 6).
Performance of RF models
RF models were constructed at optimized mtry and 
ntree for each input feature separately and performance 
of these models were evaluated using 10-fold cross vali-
dation and on the validation set (Additional file  1: Text 
Table 1 Annotation and coverage of MERCI motifs extracted from anti-inflammatory epitopes
For example “hydrophobic hydrophobic tiny F charged” motif is found in 22 unique anti-inflammatory epitopes
S. no. Motif Coverage
1. Hydrophobic hydrophobic tiny F charged 22
2. Hydrophobic L hydrophobic hydrophobic small polar hydrophobic polar polar 20
3. Hydrophobic I hydrophobic hydrophobic hydrophobic hydrophobic hydrophobic polar polar 18
4. Polar L aliphatic hydrophobic positive 17
5. Hydrophobic aliphatic hydrophobic aliphatic small polar hydrophobic polar polar 17
6. Hydrophobic hydrophobic small hydrophobic polar hydrophobic polar Q 17
7. L hydrophobic aliphatic small polar hydrophobic polar polar 16
8. Hydrophobic polar hydrophobic L polar hydrophobic hydrophobic polar tiny 16
9. Hydrophobic L polar polar small small hydrophobic hydrophobic 16
10. Hydrophobic aliphatic polar small hydrophobic charged polar polar hydrophobic 16
11. Hydrophobic hydrophobic hydrophobic tiny F charged 16
12. Hydrophobic hydrophobic tiny F charged hydrophobic 16
13. small aliphatic E N 16
Fig. 6 ROC plots of prediction models developed using SVMlight as machine learning technique; a 10-fold cross validation, b validation dataset
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S1). Performance of RF model was comparable to SVM 
models. For amino acid, dipeptide and selected tripep-
tide composition features SVM showed MCC of 0.37, 
0.44 and 0.51, whereas, RF showed MCC of 0.39, 0.43 
and 0.59 (Table 2 and Additional file 1: Table S2). The RF 
model constructed using selected tripeptide composi-
tion features displayed higher performance as compared 
to SVM, using 10-fold cross validation. However, on the 
validation set, the same RF model showed the MCC of 
0.31 which is much lower as compared to the MCC (0.43) 
shown by SVM model (Table  3 and Additional file  1: 
Table S3). Hence, SVM models were implemented as 
the default model for the construction of hybrid models. 
Performance of RF models was also evaluated on the bal-
anced dataset using 10-fold cross validation and on vali-
dation set (Additional file 1: Tables S4 and S5). Detailed 
description of machine learning comparison and RF 
models optimization and performance has been provided 
in Additional file 1: Text S1.
Hybrid model
TPC-based SVM model yielded the best accuracy among 
the three composition-based models. However, to further 
improve the efficiency of models, hybrid models were 
constructed for AAC, DPC, and TPC based models by 
combining each one with the motif features. The hybrid 
of AAC-based model (AAC_HYB) with motif features 
performed with 71.1% accuracy, whereas, the hybrid 
of DPC-based model (DPC_HYB) with motif features 
showed an accuracy of 74.34%. The hybrid of TPC-based 
model with motif features (TPC_HYB) was the best per-
forming among all hybrid models. It showed the highest 
accuracy of 78.1%, MCC of 0.58 and an area under curve 
(AUC) of 0.86 (Fig. 6).
Performance on validation dataset
The performance of all models was evaluated on the 
validation data (Table  3   and Fig.  6). This evalua-
tion was carried out in addition to cross-validation 
to ensure that the obtained results were not due to 
over-optimization. TPC_HYB model which showed 
the highest accuracy in 10-fold cross validation also 
performed well on the validation dataset (72%). These 
results attest that the observed results were not due to 
over-optimization of data.
Furthermore, all the inputs such as amino acid, 
dipeptides, tripeptides etc., were processed for feature 
selection for composition and hybrid models by CfsSub-
setEval algorithm of WEKA package. This feature selec-
tion is generally carried out to reduce the input data size 
without compromising on the performance. The final 
number of input features and performances of model 
with reduced input features are mentioned in Addi-
tional file  1: Table S6. It is apparent from Additional 
file 1: Table S7 that the performances of all models were 
reduced on validation dataset, with the reduction of fea-
ture vector size, however, in case of TPC_HYB model, 
the performance showed a marginal decline on the 
validation dataset, and thus, this model with reduced 
features was integrated in the webserver for efficient 
analysis.
In addition to 10-fold cross validation, models were 
also subjected to a fivefold cross validation analysis. The 
performance of models using fivefold cross validation 
Table 2 Performance of SVM models using various sequence based features
Thre threshold, Sen sensitivity, Spe specificity, Acc accuracy, MCC Matthews correlation coefficient
Feature Thre Sen Spe Acc MCC Parameter
AAC −0.3 71.74 65.71 68.16 0.37 g:0.005:c:1:j:1
DPC −0.2 80.43 64.52 70.98 0.44 g:0.005:c:1:j:3
TPC −0.2 79.28 72.15 75.04 0.51 g:0.001:c:4:j:1
AAC_HYB −0.2 81.3 64.12 71.1 0.45 g:0.005 c:1 j:4
DPC_HYB −0.3 84.78 67.2 74.34 0.51 g:0.005 c:1 j:1
TPC_HYB −0.3 87.83 71.46 78.1 0.58 g:0.001 c:2 j:1
Table 3 Performance of  optimized prediction models 
on validation dataset
Thre threshold, Sen sensitivity, Spe specificity, Acc accuracy, MCC Matthews 
correlation coefficient
Feature Thre Sen Spe Acc MCC
AAC −0.3 72.83 63.89 67.53 0.36
DPC −0.2 81.5 65.08 71.76 0.46
TPC −0.2 71.1 72.22 71.76 0.43
AAC_HYB −0.2 72.83 62.3 66.59 0.35
DPC_HYB −0.3 80.35 61.9 69.41 0.42
TPC_HYB −0.3 78.61 67.46 72 0.45
Page 9 of 11Gupta et al. J Transl Med  (2017) 15:7 
also showed similar results. The TPC_HYB model dis-
played the maximum accuracy of 76% and also per-
formed better than the other models for sensitivity and 
specificity values. It showed an MCC value of 0.56 and an 
AUC measure of 0.85 (Additional file 1: Table S8). Result-
antly, the TPC_HYB model was incorporated in the web-
server for epitope prediction.
Balanced dataset which contained 690 samples from both 
positive and negative dataset was also used to examine the 
performance of SVM models. The TPC_HYB model dis-
played the maximum accuracy of 77.8% and MCC value of 
0.56. The sensitivity and specificity of this model was also 
higher than other models (Additional file 1: Table S9).
Web server and tools
A webserver was constructed for hosting a number of 
tools developed in this study for predicting the anti-
inflammatory nature of peptide/protein antigens. These 
tools employ the validated best performing model devel-
oped in the study. The web server also incorporates sev-
eral other analysis tools as described below.
Peptide prediction
This module is developed for predicting the anti-inflam-
matory nature of small length peptides. The user can sub-
mit a single peptide or a batch of peptides with lengths 
ranging from 4 to 30 amino acids. A threshold option is 
also provided which can be tuned to increase the strin-
gency of positive prediction. Queries are passed through 
anti-inflammatory epitope prediction pipeline and the 
results are displayed as a table which shows the pre-
diction of a peptide as anti-inflammatory or non anti-
inflammatory based on SVM or RF scores.
Every peptide sequence in the results table is pro-
vided with option for its virtual screening and design 
which is an additional feature that screens the variants 
of the peptides for anti-inflammatory property. Vari-
ants are created by substituting each amino acid posi-
tion by all the 19 other naturally occurring amino acids. 
This option enables the user to check the anti-inflam-
matory nature of peptides that are similar to the query 
peptides.
Protein scan
To determine the antigenic regions in a full-length pro-
tein which can induce anti-inflammatory responses, this 
module has been designed to allow the submission of 
query proteins with longer lengths. This tool divides the 
protein sequences into smaller peptides and runs through 
the same prediction pipeline. The user can also select the 
desired window length of peptides for prediction. Virtual 
screening option is also provided similar to the peptide 
prediction module.
Epitope mapping
In addition to the above tools, the user may wish to map 
the experimentally validated anti-inflammatory antigenic 
regions on a query protein. This module map experimen-
tally validated AIEs from IEDB database on the protein 
query sequence. The results are displayed as an align-
ment with links to the related assay provided by IEDB 
database.
Similarity search
Unlike the epitope mapping tool, this module identi-
fies the similar regions in the query peptide/protein 
and experimentally validated AIEs. Smith–Watermann 
search of query sequence in IEDB database is carried for 
displaying the top hits. Results are shown as alignments 
with links to related assay in IEDB database.
Discussion
Anti-inflammatory drugs have widespread applica-
tions in the field of therapeutics because of their role in 
the reduction of swelling and inflammation. The novel 
peptides with anti-inflammatory properties may also 
be used as therapeutic agents against several diseases 
such as Alzheimer’s, rheumatoid arthritis as well as gut 
infections. Inflammatory response at the site of infec-
tion is caused due to the production of prostaglandin, 
thromboxane, etc. along with a release of histamine and 
kinin. Though it has been shown that nature of activat-
ing signal, timing, and sequence of cytokine action as 
well as experimental models affect their pro- or anti-
inflammatory properties, IL4, IL-10, IL-13, IFN-alpha 
and transforming growth factor-beta are widely recog-
nized as anti-inflammatory cytokines [30]. Studies have 
shown that anti-inflammatory drugs function by down-
regulating the expressions of 5-LOX, COX-2, MMPs and 
NF-κB [31]. These drugs show low efficacy in curing the 
inflammation and leads to hypersensitivity reactions 
and deterioration of the immune system [32]. Due to the 
limitation of small molecule drugs, peptide-based drugs 
appear as better candidates in curing inflammation [33]. 
Thus, developing an in silico method for predicting the 
anti-inflammatory properties of newly synthesized or 
recently discovered amino acid sequence (peptide) is 
very valuable.
For the identification of anti-inflammatory targets, pos-
itive (anti-inflammatory) and negative (non anti-inflam-
matory) samples data was curated from immune epitope 
database which is a well-known reference database and 
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contain the experimentally validated data. Using a good 
input quality data is a key for the application of machine 
learning techniques.
Compositional analysis revealed the presence of 
selected amino acids in abundance in AIEs, which is 
supported by other independent studies. For example, 
an amino acid stretch of 8-16 of SV-IV, which is rich 
in Ser and Gln residues, has been reported to exhibit 
anti-inflammatory properties [34]. Motif based analysis 
helped to determine the patterns in binding sites of tar-
get peptides on MHC molecules. Annotation of MERCI 
motifs from unique AIEs revealed that ‘hydrophobic 
hydrophobic tiny F charged’ had the maximum coverage. 
From this study, it was also observed that certain HLA 
alleles such as HLA-DRB1*04:01 alleles were more fre-
quent in anti-inflammatory positive assays. Interestingly, 
the HLA-DRB1*04:01 allele has been associated with an 
increased occurrence of rheumatoid arthritis in the Cau-
casian population [35].
Furthermore, three different types of compositional 
analysis including amino acid, dipeptide and tripeptide 
composition were carried out to obtain the information 
of signature sequences, of which TPC_HYB (tripeptide 
hybrid with motifs derived weightage) was selected and 
included as the final model for webserver as a default 
prediction model. TPC (tripeptide composition) 
based RF model was also included at the webserver 
as an additional prediction model. The availability of 
two machine learning models provides flexibility and 
options to the users to predict epitopes using two dif-
ferent methods.
Conclusion
The inherent ability of anti-inflammatory molecules to 
induce anti-inflammatory cytokines has the potential 
to play a major role in immunology and peptide thera-
peutic applications. Hence, an attempt has been made 
to identify sequence-based signatures of anti-inflam-
matory peptides and a machine learning tool has been 
developed for the prediction of anti-inflammatory 
epitopes. The observed accuracy values attest the per-
formance of the tool and to our knowledge, it is the only 
available tool for the prediction of anti-inflammatory 
epitopes. Thus, the identification of anti-inflammatory 
target peptide sequences using this computational 
server provides valuable leads for experimental valida-
tions for the scientific community. The developed com-
putational tools for investigation of anti-inflammatory 
sites have been made freely available for academic usage 
as a web server.
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